Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-247

5 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-247-90 (Atorvastatin 20 mg 30 Bottle Label)

71205-247-90 (Atorvastatin 20 mg 30 Bottle Label)
The label shows Atorvastatin Calcium 20 mg film-coated tablets, provided by Proficient Rx LP. The package contains 90 tablets with each tablet equivalent to 20 mg Atorvastatin Calcium USP. Manufactured by Intas Pharmaceuticals Limited, India, the tablets are white to off-white, oval, biconvex, and debossed with 'FF2' on one side. Storage instructions specify 20°-25°C (68°-77°F). The label includes the NDC 71205-247-90 and cautions to keep medication out of reach of children.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

Figure (Atorvastatin Calcium Figure 1)
A cumulative incidence line graph comparing Atorvastatin and Placebo over 3.5 years. The y-axis shows cumulative incidence percentage, while the x-axis shows time in years. The Atorvastatin group exhibits a lower cumulative incidence than the Placebo group throughout the timeline.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

Figure (Atorvastatin Calcium Figure 2)
A Kaplan-Meier cumulative hazard graph depicting the time to first primary endpoint over four years of follow-up comparing Atorvastatin calcium tablets 20 mg (solid line) versus placebo (dashed line). The y-axis shows cumulative hazard percentage, and the x-axis shows time in years. Atorvastatin has a lower cumulative hazard than placebo during the period.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

Figure (Atorvastatin Calcium Figure 3)
A Kaplan-Meier survival curve showing subjects experiencing a major cardiovascular event over time in years, comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The graph illustrates a lower event rate over 5 years for the 80 mg dose, with a hazard ratio (HR) of 0.78 and p-value of 0.0002.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical Structure (Atorvastatin Calcium Structure)
Chemical structure of atorvastatin calcium trihydrate, depicting the molecular arrangement including fluorophenyl, phenyl, and hydroxyl groups with calcium ion and water of hydration indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.